Delivery Order SPE2DB22D2006-SPE2DB24FW0FE

Award Date 5/9/24
Potential Completion Date 5/10/24
Potential Value $33K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $36,639.83 fixed-price delivery order is for the supply of CONCERTA ER 36 MG TABLET 100S, a pharmaceutical product. The contract has an ultimate completion date of December 20, 2023. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the...
This federal contract award, with ID SPE2DX22D0010|SPE2D823FDT97, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $32,295.87 firm fixed-price delivery order is for the pharmaceutical product Concerta ER Tabs 36mg. The contract has no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the...
This federal contract award, valued at $32,589.98, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The award is for the delivery of Concerta ER 27 mg tablets, a pharmaceutical product, to support military healthcare programs. The contract has an ultimate completion date of May 3, 2024 and is a firm fixed-price delivery order. It is not designated as a set-aside contract. Amerisourcebergen Drug Corp holds a significant $999,999,999...
This federal contract award, with an ID of SPE2DB22D2007|SPE2DB23FJ2KP, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of 4,560,939 units of Concerta ER 36 mg tablets, with a ceiling value of $32,653.24 and a completion date of May 16, 2023. This is a firm fixed-price delivery order contract, and there is no set-aside designation. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,559,605,609 units of Concerta ER 36 mg tablets. The $87,635.10 firm-fixed-price contract has a completion date of January 11, 2023. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $7,604.35 firm-fixed-price delivery order is for the provision of Concerta ER 36 MG tablets, a prescription medication. The contract has an ultimate completion date of March 11, 2024. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of Concerta ER 27 mg tablets. The $6,768.07 firm fixed price delivery order was issued by the Defense Logistics Agency (DLA) Troop Support Medical, a defense agency that provides medical supplies and equipment to military treatment facilities. The contract has a completion date of September 16, 2024 and is not set aside for any specific business type. Amerisourcebergen holds...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $5,821.64 firm-fixed-price delivery order is for the supply of 100 units of the medication Concerta ER 18 mg tablets. The contract has an ultimate completion date of May 1, 2024. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that runs through November 2026. This IDC...
This federal contract award, valued at $12,779.72, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is a delivery order for the pharmaceutical product Concerta ER 36 mg tablet, with a period of performance through February 5, 2024. The contract was awarded on a full and open competition basis, with no set-aside designation. Amerisourcebergen Drug Corp, a major pharmaceutical distributor, holds a significant Indefinite...
This federal contract award is for the delivery of Concerta ER 36 mg tablets to the Defense Logistics Agency (DLA). The $8,527.02 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of the pharmaceutical distribution company Cencora, Inc. The contract has an ultimate completion date of February 13, 2024 and is not designated with a set-aside. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
  • SPE2DB22D2006
    Indefinite Delivery Contract
  • SPE2DB22D2006-SPE2DB24FW0FE
    Delivery Order

This federal contract award, identified as SPE2DB22D2006|SPE2DB24FW0FE, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract, valued at $33,239.04, is for the delivery of the pharmaceutical product Concerta ER 36 mg Tablet in quantities of 100s. The award has an ultimate completion date of May 10, 2024 and is a Firm Fixed Price Delivery Order contract, with no set-aside designation.

Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. This IDC serves as the primary vehicle for the company to provide a comprehensive range of pharmaceutical products and medical supplies to support the Department of Defense and military healthcare programs globally. Amerisourcebergen also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at up to $750,000 through May 2024, for similar medical products and prescription drugs.

Generated 5/16/25, 12:22 PM